VVOSVivos Therapeutics, Inc.

VVOS Stock Price, Valuation & Chart | Vivos Therapeutics, Inc.

Compare

$0.170+0.00 (+2.43%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices VVOS intrinsic value VVOS calculated fair value vs price

Overview Financials Dividends Ratios

VVOS Historical price chart

VVOS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.40M

PE Ratio-0.09

EPS-1.9

Trading Volume7.41M

Today's High/Low0.18/0.16

Dividend Yield0.00

52 Week High/Low4.62/0.16

Shares Outstanding13.89M

VVOS Financial Statement

VVOS Analyst ratings

VVOS Analysis & performance metrics

VVOS Company profile

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep…

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.…

VVOS Management team

Name

Position

Susan McCullough

Co-Founder & Executive Vice President of Operations

Ruth Hembree

Senior Vice President of Practice Services

R. Kirk HuntsmanCEO

Co-Founder, Chairman of the Board & Chief Executive Officer

Nicholas M. DeGennaro

Senior Vice President of Mergers and Acquisition Group

John Ballard

Senior Vice President of Technology

Bradford K. AmmanCFO

Chief Financial Officer, Treasurer & Secretary

Todd Huntsman

Co-Founder & Senior Vice President of Product and Technology

RaeAnn Byrnes

Co-Founder and Senior Vice President of Events & Clinical Advisory Services

Name

Position

Susan McCullough

Co-Founder & Executive Vice President of Operations

Ruth Hembree

Senior Vice President of Practice Services

R. Kirk HuntsmanCEO

Co-Founder, Chairman of the Board & Chief Executive Officer

Nicholas M. DeGennaro

Senior Vice President of Mergers and Acquisition Group

John Ballard

Senior Vice President of Technology

Bradford K. AmmanCFO

Chief Financial Officer, Treasurer & Secretary

Todd Huntsman

Co-Founder & Senior Vice President of Product and Technology

RaeAnn Byrnes

Co-Founder and Senior Vice President of Events & Clinical Advisory Services

Management Team

Susan McCullough

Co-Founder & Executive Vice President of Operations

Ruth Hembree

Senior Vice President of Practice Services

R. Kirk HuntsmanCEO

Co-Founder, Chairman of the Board & Chief Executive Officer

Nicholas M. DeGennaro

Senior Vice President of Mergers and Acquisition Group

John Ballard

Senior Vice President of Technology

Bradford K. AmmanCFO

Chief Financial Officer, Treasurer & Secretary

Todd Huntsman

Co-Founder & Senior Vice President of Product and Technology

RaeAnn Byrnes

Co-Founder and Senior Vice President of Events & Clinical Advisory Services

Management

Susan McCullough

Co-Founder & Executive Vice President of Operations

Ruth Hembree

Senior Vice President of Practice Services

R. Kirk HuntsmanCEO

Co-Founder, Chairman of the Board & Chief Executive Officer

Nicholas M. DeGennaro

Senior Vice President of Mergers and Acquisition Group

John Ballard

Senior Vice President of Technology

Bradford K. AmmanCFO

Chief Financial Officer, Treasurer & Secretary

Todd Huntsman

Co-Founder & Senior Vice President of Product and Technology

RaeAnn Byrnes

Co-Founder and Senior Vice President of Events & Clinical Advisory Services

Total 8 executives

VVOS Frequently asked questions

What is Vivos Therapeutics, Inc. (VVOS) Stock Price?

Current stock price of Vivos Therapeutics, Inc. (VVOS) stock is $0.170. The stock price is +2.43% higher in the session. The intraday range can be seen from this page. Volume of Vivos Therapeutics, Inc. (VVOS) stock is 7.41M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Vivos Therapeutics, Inc. (VVOS) stock price going up or down today?

The stock price of Vivos Therapeutics, Inc. (VVOS) can change with earnings, company news, and overall market sentiment. Vivos Therapeutics, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Vivos Therapeutics, Inc. stock expensive at its current price?

Whether Vivos Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VVOS on this page is -0.09. EPS on this page is -1.90. Compare those figures with peers and growth expectations before deciding if the current Vivos Therapeutics, Inc. price is justified.

How has the stock price of Vivos Therapeutics, Inc. (VVOS) performed historically?

Historical performance for Vivos Therapeutics, Inc. (VVOS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VVOS reacted to past earnings and market events.

Should I buy Vivos Therapeutics, Inc. (VVOS) stock, at this price?

Buying Vivos Therapeutics, Inc. (VVOS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.